BMJ

Awake versus asleep deep brain stimulation for Parkinson’s disease: a critical comparison and meta-analysis

Objective No definitive comparative studies of the efficacy of ‘awake’ deep brain stimulation (DBS) for Parkinson’s disease (PD) under local or general anaesthesia exist, and there remains significant ...
BMJ

Elementary visual hallucinations, blindness, and headache in idiopathic occipital epilepsy: differentiation from migraine

This is a qualitative and chronological analysis of ictal and postictal symptoms, frequency of seizures, family history, response to treatment, and prognosis in nine patients with idiopathic occipital ...
BMJ

The impact and prognosis for dystonia in childhood including dystonic cerebral palsy: a clinical and demographic tertiary cohort study

Introduction and methods The impact of dystonia in childhood is poorly understood. We report our experience of referrals between 2005 and 2012. Results Of 294/315 assessable children, 15/294 had pure ...
BMJ

Botulinum toxin and spasticity

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...
BMJ

Heterogeneity of small vessel disease: a systematic review of MRI and histopathology correlations

1 Alzheimer Centre and VU University Medical Centre, Amsterdam, The Netherlands 2 Department of Neurology, VU University Medical Centre, Amsterdam, The Netherlands 3 Department of Neurology and MRI ...
BMJ

“Stops walking when talking” as a predictor of falls in people with stroke living in the community

Objective: To test “Stops walking when talking” (SWWT) as a predictor of falls among people with stroke living in the community. Methods: People with stroke were identified through hospital records.
BMJ

Prognostic relevance of quantitative and longitudinal MOG antibody testing in patients with MOGAD: a multicentre retrospective study

Background IgG antibodies against myelin oligodendrocyte glycoprotein (MOG-IgG) define a subset of associated disorders (myelin oligodendrocyte glycoprotein associated disorders (MOGAD)) that can have ...
BMJ

Practical use of risdiplam (EVRYSDI▾) in Individuals with Spinal muscular atrophy

4 Gastroenterology Department, Great Ormond Street Hospital NHS Foundation Trust, London, UK 5 Department of Urology, Royal Hallamshire Hospital NHS Foundation Trust, Sheffield, UK 6 Paediatric ...
BMJ

Diffuse brain oedema in idiopathic intracranial hypertension: a quantitative magnetic resonance imaging study

Correspondence to: Dr Mark Bastin Medical and Radiological Sciences (Medical Physics), University of Edinburgh, Western General Hospital, Crewe Road, Edinburgh EH4 2XU, UK; mebskull.dcn.ed.ac.uk ...
BMJ

Purkinje cell loss is the major brain pathology of spinocerebellar ataxia type 10

4 Department of Pathology, College of Medicine, University of Florida, Gainesville, Florida, USA Correspondence to Dr Tetsuo Ashizawa, Department of Neurology, College of Medicine, University of ...
BMJ

Predictors of cognitive deterioration in subjective cognitive decline: evidence from longitudinal studies and implications for SCD-plus criteria

Background Subjective cognitive decline (SCD) is an early manifestation of cognitive deterioration (CD) in some individuals. Therefore, it is worthwhile to conduct a systematic review and ...
BMJ

Efficacy and safety of rituximab in myelin oligodendrocyte glycoprotein antibody-associated disorders compared with neuromyelitis optica spectrum disorder: a systematic review ...

Background Rituximab (RTX) efficacy in patients with myelin oligodendrocyte glycoprotein (MOG) antibody-associated disorders (MOGADs) is still poorly understood, though it appears to be lower than in ...